期刊
ACTA PHARMACOLOGICA SINICA
卷 39, 期 7, 页码 1073-1084出版社
ACTA PHARMACOLOGICA SINICA
DOI: 10.1038/aps.2018.30
关键词
microRNA; cardiovascular diseases; biomarker; therapeutic targets
资金
- National Natural Science Foundation of China [81400281, 81770372]
- American Diabetes Association [1-15-BS-018, 1-18-IBS-082]
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the world. Although considerable progress has been made in the diagnosis, treatment and prognosis of CVD, there is still a critical need for novel diagnostic biomarkers and new therapeutic interventions to decrease the incidence of this disease. Recently, there is increasing evidence that circulating miRNAs (miRNAs), i.e. endogenous, stable, single-stranded, short, non-coding RNAs, can be used as diagnostic biomarkers for CVD. Furthermore, miRNAs represent potential novel therapeutic targets for several cardiovascular disorders. In this review we provides an overview of the effects of several CVD; including heart failure, acute myocardial infarction, arrhythmias and pulmonary hypertension; on levels of circulating miRNAs. In addition, the use of miRNA as therapeutic targets is also discussed, as well as challenges and recommendations in their use in the diagnosis of CVD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据